A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
Home Therapies Gastric Stimulation Intrapace Abiliti Gastric Stimulator for the Treatment of Obesity

Intrapace Abiliti Gastric Stimulator for the Treatment of Obesity

Intrapace Ability IPG for Treatment of ObesityIntrapace was founded in Mountain View, CA by Mir Imran in 2001 to develop an implantable system for the treatment of obesity.  Once implanted and activated, the Abiliti system is designed to detect when a person consumes food or drink. When food or drink is detected, the system delivers a series of low-energy electrical impulses to the stomach intended to create a feeling of fullness.

In January 2011 Intrapace received the CE Mark for the Ability system.

The Ability IPG connects to the stomach via a lead that integrates the food sensor and stimulation electrodes. The sensor is able to detect food and drink and can trigger the abiliti stimulator device to create a feeling of fullness. These eating events, along with physical activity the patient engages in, are automatically recorded and available for downloading to a personal computer using the connect.abiliti Wand.

Click here for Intrapace’s patents.





Connection of the Intrapace Ability IPG to the stomach


 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
1 Comment  comments 

One Response

  1. gjdemag@gmail.com

    Interested in FDA approval date for U. S. patients.